Xcout Intel
QurieGen
QurieGen is a precision medicine company headquartered in Nijmegen, Netherlands, that uses single-cell AI to transform drug development and create treatments more efficiently.
Subscribe to see QurieGen’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
QurieGen at a glance
QurieGen is a drug discovery company headquartered in Netherlands. Its most recent funding round, Pre-Seed, raised $2.4M in April 2025. Xcout tracks 2 named people at QurieGen, including Kinga Matula (CEO and co-founder).
QurieGen leadership
- Kinga MatulaCEO and co-founder
- Maciej JarzabCOO and co-founder
QurieGen funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Pre-Seed | $2.4M | 11 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
QurieGen competitors
A few of QurieGen's closest competitors — see the full list of competitors and alternatives →
Cassidy Bio is an AI-first biotechnology company founded in 2024 and based in Israel that is developing a programmable platform for gene editing. The company utilizes a genomic foundation model powered by artificial intelligence to design safer and more scalable gene editing therapies across various guides, editors, and delivery contexts.
Cellyrix Therapeutics is an Israeli biotechnology company that develops targeted cancer therapies by leveraging single-cell RNA sequencing and artificial intelligence. The firm operates as an oncology-focused drug discovery venture headquartered in Rehovot, Israel.
RyboDyn is a biotechnology company that uses its proprietary RyboCypher platform, combining RNA sequencing and AI, to decode the dark proteome and identify hidden cancer targets. The company develops next-generation, antibody-based immunotherapies designed to address critical unmet needs in cancer treatment.
Gero is a biotechnology company headquartered in Singapore with a U.S. subsidiary, combining physics, biology, and artificial intelligence to decode human biology and develop life-changing medicines.
Coding Bio is an Oxford-based biotechnology company that combines a high-throughput wet lab and machine learning platform to screen, build, and deliver fully-assembled modular therapies like CARs and BiTEs.
Curreio is a biotechnology company founded in 2019 and headquartered in Japan. It operates as a contract research organization (CRO) providing drug discovery and development support services utilizing high-resolution structural analysis with cryo-electron microscopy technology.
Get QurieGen's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on QurieGen in Xcout Intel
- 2 named people with titles, LinkedIn and board committees
- 1 funding round with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access